The nonclinical safety profile of the 5-HT4 partial agonist, PF-04995274, supported clinical development for symptomatic treatment of Alzheimer's disease

Saved in:

Bibliographic Details
Published in	Alzheimer's & dementia Vol. 7; no. 4; p. S771
Main Authors	Pettersen, Betty, Harris, Peter, Steidl, Jill, Marcek, John, Mirsky, Michael, Pardo, Ingrid, Papanikolaou, Alexandros
Format	Journal Article
Language	English
Published	Elsevier Inc 01.07.2011
Subjects	Neurology
Online Access	Get full text

Loading…

More Information
ISSN:	1552-5260 1552-5279
DOI:	10.1016/j.jalz.2011.05.2216